- Home
- BSM vs CNTA Comparison
BSM vs CNTA Comparison
Compare BSM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSM
- CNTA
- Stock Information
- Founded
- BSM 1876
- CNTA 2020
- Country
- BSM United States
- CNTA United Kingdom
- Employees
- BSM N/A
- CNTA N/A
- Industry
- BSM Oil & Gas Production
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BSM Energy
- CNTA Health Care
- Exchange
- BSM Nasdaq
- CNTA Nasdaq
- Market Cap
- BSM 2.5B
- CNTA 2.3B
- IPO Year
- BSM 2015
- CNTA 2021
- Fundamental
- Price
- BSM $12.79
- CNTA $21.58
- Analyst Decision
- BSM Hold
- CNTA Strong Buy
- Analyst Count
- BSM 1
- CNTA 11
- Target Price
- BSM $13.00
- CNTA $30.60
- AVG Volume (30 Days)
- BSM 518.4K
- CNTA 1.4M
- Earning Date
- BSM 11-03-2025
- CNTA 11-11-2025
- Dividend Yield
- BSM 9.38%
- CNTA N/A
- EPS Growth
- BSM N/A
- CNTA N/A
- EPS
- BSM 1.16
- CNTA N/A
- Revenue
- BSM $413,675,000.00
- CNTA $15,000,000.00
- Revenue This Year
- BSM $10.58
- CNTA N/A
- Revenue Next Year
- BSM $14.68
- CNTA N/A
- P/E Ratio
- BSM $11.00
- CNTA N/A
- Revenue Growth
- BSM N/A
- CNTA 118.88
- 52 Week Low
- BSM $11.78
- CNTA $9.60
- 52 Week High
- BSM $15.66
- CNTA $23.24
- Technical
- Relative Strength Index (RSI)
- BSM 54.37
- CNTA 56.29
- Support Level
- BSM $11.78
- CNTA $15.01
- Resistance Level
- BSM $12.63
- CNTA $23.24
- Average True Range (ATR)
- BSM 0.17
- CNTA 1.14
- MACD
- BSM -0.59
- CNTA -0.76
- Stochastic Oscillator
- BSM 99.77
- CNTA 92.86
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.